The Petri Dish: Sarepta hit with clinical hold, Decibel stock soars

The FDA has placed a clinical hold on a Duchenne muscular dystrophy drug made by Sarepta Therapeutics Inc.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 30, 2022 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news